You Say You Want a Revolution. . .
Source: Patrick Cox, The Daily Reckoning  (12/13/12)
"As investors, we have a huge opportunity to invest in early-stage, revolutionary companies working on plant- and animal-based health solutions that bypass the lengthy and extremely expensive FDA approval process." More >

Two Biotech Names Without the Microcap Roller Coaster
Source: George S. Mack of The Life Sciences Report  (12/13/12)
Investors familiar with Zacks Investment Research know that the company is small-cap focused and that it leans heavily toward companies that don't get much coverage from Wall Street. The idea is to produce the kind of sophisticated research you might find in the more recognizable names that get aired on financial television and other media. Battered and forgotten names can be interesting for investors willing to take another look, and biotech can be a particularly rich field for investors looking for turnaround ideas. In fact, this is where Zacks Senior Biotechnology Analyst Jason Napodano is at home. He's not afraid to go all-in with ideas that are anathema to the Street. More >

How to Buy Silver: The Best Is Yet To Come in 2013
Source: Larry Spears, Money Morning  (12/12/12)
"Purists view holding actual physical precious metals like gold and silver as the only true means of hedging against inflation and gaining an effective long-term store of value." More >

Porter Stansberry: Gold and Real Estate Are My Hedges for the Fiscal Cliff
Source: Karen Roche of The Gold Report   (12/12/12)
With nary a glimmer of hope that economic sense will supplant political expedience, Stansberry & Associates Investment Research Founder Porter Stansberry expects rampant inflation to roar in once the cost of capital rises. How is he preparing himself? Stansberry tells The Gold Report he continues to buy and hold gold and also discusses how real estate can cushion against the fiscal cliff. More >

How Gold Miners Can Leverage the Price of Gold
Source: Frank Holmes, Frank Talk  (12/12/12)
"Gazing into their crystal balls last week, Wall Street firms interpreted differing futures for gold next year. Morgan Stanley awarded gold the 'best commodity for 2013' while Goldman Sachs called the end of the metal’s hot streak." More >

Cliff Spells Danger for Biotechs
Source: Alex Philippidis, Genetic Engineering and Biotechnology News  (12/12/12)
"If Obama and Congress cannot agree, key agencies face cuts while tax changes would dampen new investment." More >

Governors Take Energy into Their Own Hands
Source: T. Boone Pickens  (12/12/12)
"Power, in the form of innovation and ideas, will shift from the nation's capital to the capitals of the 50 states." More >

Why the Pros Bet Contrarian: Sprott Execs Bambrough and Dimitriadis
Source: Zig Lambo of The Energy Report  (12/11/12)
When oil was in the limelight, Sprott's Bambrough and Dimitriadis went for wallflower companies in beaten-down sectors. Since 2007, the pair has seen striking highs and lows in natural gas, coal and potash and invested accordingly, infusing companies with much-needed capital and creating startling profits during sector upswings. Read on to benefit from the wisdom these two successful fund managers share in this Energy Report interview and find out where the duo is looking next for major growth. More >

A Critical Year in Review: What's Next?
Source: The Critical Metals Report Editors  (12/11/12)
Every great mining story begins from the ground up. This is as true of critical metals as it is for gold and silver. Many investors took losses by chasing the pie-in-the-sky potential every publicly listed rare earth stock seemed to promise. Since its debut 18 months ago, The Critical Metals Report has focused on the goods in the ground, striving to present valuable insights on an oft-misrepresented sector, sharing related stories as they emerged. As the year comes to a close and we prepare to extend our coverage further, we are revisiting our most popular expert interviews from 2012. Yes, it's still rough out there for miners, but when you think nothing's looking up, look down. More >

How Oil and Gas Investors Are Playing the 'New World Order'
Source: Peter Krauth, Money Morning  (12/11/12)
"Every day it seems the energy scene is changing at a lightning pace, creating a new world order in energy." More >

Natural Gas: To Export or Not to Export?
Source: Matt Insley, The Daily Reckoning  (12/11/12)
"According to a report from the National Economic Research Associates, the U.S. would enjoy a 'net benefit' from exporting natural gas." More >

Top 14 Abused Prescription Drugs
Source: Genetic Engineering and Biotechnology News  (12/11/12)
"Celebrities ranging from Michael Jackson to Rush Limbaugh and from Heath Ledger to Elvis Presley have battled (and, in many cases, lost the battle with) prescription drug addiction. So, which prescription drugs are the biggest culprits?" More >

Breaking Down a Biotech Winner
Source: Alex Daley, Casey Research  (12/11/12)
"The cancer research arena has been exploding over the past few years with the goal of developing more targeted, less-toxic therapies—in other words, to do a better job killing cancer cells while leaving healthy cells alone. More >

Peter Grandich: What a Turnaround in Junior Gold Mining Stocks Will Look Like
Source: Brian Sylvester of The Gold Report  (12/10/12)
The fundamentals at many junior mining companies have improved, yet their stock prices continue to languish. In this interview with The Gold Report, market guru Peter Grandich gives his thoughts on when this may end and where gold is headed in 2013, and names some of his picks in unlikely jurisdictions. More >

Secondary Bottom Coming in Gold Stocks
Source: Jordan Roy-Byrne, The Daily Gold  (12/10/12)
"We think the current probabilities favor a secondary bottom in the gold stocks and very soon the risk/reward dynamic will be heavily in favor of longs." More >

Gold Confiscation: Lessons from the 20th Century
Source: Adrian Ash, Bullion Vault  (12/10/12)
"Because gold is no longer central to the world's monetary system, so-called 'confiscation' looks a very 20th century phenomenon today. But that may well change." More >

Graphene: Thinnest Material Ever Made
Source: The Economic Times  (12/10/12)
"Sheets of it are only one atom thick. Expect it in a gadget near you within five years." More >

Sprott's Michael Kosowan on Surviving Death by Paper Cut in Today's Mining Equity Market
Source: Sally Lowder of The Gold Report   (12/7/12)
An investment executive at Sprott Global Resource Investments Ltd., Michael Kosowan is working by three sayings these days: "Well bought is half sold," "Small is beautiful" and "Necessity is the mother of invention." In this Gold Report interview, Kosowan talks about the challenges mining companies face and shares some jurisdictions that offer outsized returns. More >

Junior Gold-Mining Sector Distressing for Investors
Source: Bob Kirtley, SK Options Trading  (12/7/12)
"We will take a quick look at the GDXJ to see if we can discern any trends that may help us position our hard-earned cash for future growth." More >

Weighing the Risks in International Oil Plays
Source: George S. Mack of The Energy Report  (12/6/12)
Explorers and producers need to go where the oil is. But how do you balance resource upside potential with jurisdictional risk? Amin Haque of Stonecap Securities argues that jurisdiction risk isn't a deal-breaker if management knows how to mitigate it. In this interview with The Energy Report, Haque shares some companies that meet those criteria, favoring redevelopment plays that avoid exploration risk. Find out which teams are using new technologies to turn proven reserves into economic international projects. More >

Ross Silver on How to Find the Perfect Combo of Biotech Science and Market Savvy
Source: George S. Mack of The Life Sciences Report   (12/6/12)
Many components go into building a successful biotech company, but excellent management is a keystone. Combine good management with an innovative product or service, and investors can possibly unlock big multiples over their original investments. So says Principal Analyst and Fund Manager Ross Silver, co-founder of Vista Partners. In this interview with The Life Sciences Report, Silver brings obscure micro-cap ideas to life and discusses why they may have mammoth potential. More >

Can Gold Keep Its Luster in 2013?
Source: Clif Droke, Gold & Silver Stock Report  (12/6/12)
"Gold is currently showing a net gain for the year-to-date." More >

Drug Companies Exert Greater Influence on Development
Source: Patricia Dimond, Genetic Engineering and Biotechnology News  (12/6/12)
"In the face of the extraordinary time and cost pressures, companies are making changes to improve R&D efficiency, addressing those factors within their control, such as dumping drug candidates that clearly don't have a chance of making it." More >

Letting Biotech Companies 'Patent Nature' Could Be a Huge Boon for Investors
Source: Michael A. Robinson, Money Morning  (12/6/12)
"Clearly the courts have a vested interest in making sure that American firms continue to get the protections they need to justify spending so much time, money and effort to design new products. On the other hand, the plaintiffs raise a point in this case that cuts to the heart of biotech research—can a company really lay claim to a gene?" More >

Pent-Up Potential for Precious Metals in 2013: Jason Hamlin
Source: Brian Sylvester of The Gold Report   (12/5/12)
Debt, not the fiscal cliff, is what concerns Jason Hamlin, publisher of the Gold Stock Bull newsletter, and if his prediction of a split in the EU comes to pass, it will bolster the case for gold equities. In this Gold Report interview Hamlin shares his preference for royalty streamers and prospect generators in the gold space and explains his attraction to graphite. More >